Atlas Trials

Effect of SGLT-2 Inhibitor Dapagliflozin on Glycemic Variability in Patients With Diabetes Mellitus Type 2

Clinical trial NCT02719756 · UNKNOWN

Trial details

NCT number
NCT02719756
Sponsor
Research Clinical Centre of the Russian Railways, JSC
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Diabetes MellitusHypoglycemic Episodes
Start date
2016-04-01
Primary completion
2016-10-01
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.